Related Experiment Videos
IGF-I regulates IRS-1 expression in 3T3-L1 adipocytes
1Department of Internal Medicine, Texas Tech University Health Sciences Center, 3601 Fourth Street, Lubbock, 79430, USA.
Biochemical and Biophysical Research Communications
|March 2, 1999
Summary
Insulin receptor substrate-1 (IRS-1) levels change differently with insulin and IGF-I. Low IGF-I increases IRS-1 synthesis, while insulin degrades it, impacting glucose uptake.
Area of Science:
- Biochemistry
- Cell Biology
- Endocrinology
Background:
- Insulin receptor substrate-1 (IRS-1) is crucial for insulin and IGF-I signaling pathways.
- Differential regulation of IRS-1 by insulin and IGF-I is key to understanding metabolic control.
Purpose of the Study:
- To investigate the distinct effects of insulin and IGF-I on IRS-1 expression and function in 3T3-L1 adipocytes.
- To elucidate the mechanisms underlying IGF-I-induced IRS-1 synthesis and insulin-induced IRS-1 degradation.
Main Methods:
- Treatment of 3T3-L1 adipocytes with varying concentrations of insulin and IGF-I.
- Assessment of IRS-1 protein levels and glucose uptake.
- Use of Actinomycin D, cycloheximide, and phosphatidylinositol 3'-kinase inhibitors to probe signaling pathways.
Main Results:
- Chronic insulin treatment led to IRS-1 proteolysis and decreased glucose uptake.
- Low-concentration IGF-I treatment stimulated IRS-1 synthesis, increasing glucose uptake.
- High-concentration IGF-I treatment resulted in IRS-1 down-regulation.
- Both insulin and IGF-I effects on IRS-1 were modulated by phosphatidylinositol 3'-kinase inhibitors.
Conclusions:
- IGF-I can stimulate IRS-1 synthesis, contrasting with insulin's degradative effect.
- Differential regulation of IRS-1 by insulin and IGF-I significantly impacts glucose transport.
- The findings highlight distinct roles of insulin and IGF-I in metabolic regulation via IRS-1.